Back to Baker Bros. Advisors LP Baker Bros. Advisors LP

SKYE

Showing 8 of 9 quarters

Position history for Baker Bros. Advisors LPBaker Bros. Advisors LP's holdings in Skye Bioscience, Inc.

Yes. Baker Bros. Advisors holds 1,575,243 shares of SKYE (Skye Bioscience), worth $1.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Baker Bros. Advisors has held SKYE in every 13F on record since Q2 2024, 9 quarterly filings.

Current Value

$1.1M

Current Shares

1.6M

Total Value Change

-$4.5M

Total Shares Change

+140,609

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1.6M
0.0%
$1.1M0.0%$5.54
0
2026-Q1
Increased
1.6M
+8.6%
$968,1440.0%$4.92
27
2025-Q4
Unchanged
1.5M
0.0%
$1.1M0.0%$6.00
0
2025-Q3
Unchanged
1.5M
0.0%
$5.7M0.0%$31.44
0
2025-Q2
Unchanged
1.5M
0.0%
$6.1M0.1%$33.44
0
2025-Q1
Unchanged
1.5M
0.0%
$2.3M0.0%$12.72
0
2024-Q4
Increased
1.5M
+1.1%
$4.1M0.0%$22.64
27
2024-Q3
Increased
1.4M
+186.9%
$5.6M0.1%$31.28
44

Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., Driehaus Capital Management LLC, BlackRock, Inc., Schonfeld Strategic Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used